Inspired by Emily Whitehead, along with other early patients treated with CAR-T cell therapy, Novartis embarked on a pioneering journey to reimagine cancer treatment. After 10 years, we continue to relentlessly pursue new science around cell and gene therapies to transform the lives of patients today and in the future.

Novartis is collaborating with Microsoft to apply machine learning to medicinal chemistry — part of an effort to leverage AI to bring treatments to patients more efficiently.

Inside the hunt for new antivirals to combat the current pandemic and to prepare for future ones.

From an eccentric idea to a revolution in medicine – the history of immunotherapy and a peek into its future.

Novartis researchers aim to improve the lives of patients with osteoarthritis.

We’re working to bring the hope of advanced medicine to more patients.

Targeting inflammation to fight cancer is a new approach with a long history.

A conversation with Novartis Chief Digital Officer Bertrand Bodson

Molecular glues are a new type of medicine inspired by nature’s matchmakers.

Novartis data scientists are using super-resolution microscopy to see neurodegeneration the moment it starts.

Novartis researchers are working to extend the life of organ transplants